진양제약(주) · KOSDAQ: 007370 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩93.7B | ₩113.3B | ₩120.7B |
| Operating income | ₩8.7B | ₩11.7B | ₩2.5B |
| Net income | ₩12.3B | ₩29.7B | ₩22.3B |
| Total assets | ₩119.9B | ₩227.6B | ₩267.8B |
| Total liabilities | ₩31.1B | ₩107.7B | ₩108.0B |
| Total equity | ₩88.8B | ₩119.9B | ₩159.9B |
| Share capital | ₩6.0B | ₩6.3B | ₩7.1B |
Separate statements · FY2025 operating margin 2.1% · liabilities to equity 68% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 48 (current) | 삼정회계법인 | Unqualified |
| Term 47 (prior) | 삼정회계법인 | Unqualified |
| Term 46 (two years prior) | 삼일회계법인 | Unqualified |
No change history reported in the latest annual report.
| Date | Filing | Original |
|---|---|---|
| 2026-08-13 | Half-year report (2026.06) | DART |
| 2026-06-05 | Large shareholding (5%+) report | DART |
| 2026-06-05 | Officer / major shareholder ownership report | DART |
| 2026-05-26 | Adjustment of conversion price | DART |
| 2026-05-18 | Large shareholding (5%+) report | DART |
| 2026-05-18 | Officer / major shareholder ownership report | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-03-27 | Annual general meeting results | DART |
| 2026-03-19 | Amended: Proxy solicitation reference document | DART |
| 2026-03-19 | Amended: Notice of shareholders meeting | DART |
| 2026-03-18 | Annual report (2025.12) | DART |
| 2026-03-18 | Audit report submitted | DART |
| 2026-03-05 | Reason for holding meeting on peak AGM date | DART |
| 2026-03-05 | Proxy solicitation reference document | DART |
| 2026-03-05 | Notice of shareholders meeting | DART |
| 2026-03-04 | Amended: Resolution to convene shareholders meeting | DART |
| 2026-02-23 | Amended: Cash / in-kind dividend decision | DART |
| 2026-02-23 | Resolution to convene shareholders meeting | DART |
| 2026-02-04 | Revenue or profit structure changed materially | DART |
| 2025-12-24 | Cash / in-kind dividend decision | DART |
Showing the 20 most recent of 33 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.